You are currently viewing a new version of our website. To view the old version click .
Journal: CancersVolume: 15Number: 4999
Article: A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)
  • Authors:
  • Yvonne L. E. Ang1,
  • Xiaotian Zhao2 and
  • Thanyanan Reungwetwattana3
  • et al.
Link: https://www.mdpi.com/2072-6694/15/20/4999

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.